BAL101553

· Basilea Pharmaceutica

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BAL101553, covering 2021-10-11 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2a Study of Oral BAL101553 in Adult Patients With Solid Tumors or Glioblastoma or High-grade Glioma [Phase 1, Phase 2]

See pricing